Back to Search
Start Over
Defining the phenotypic spectrum of SLC6A1 mutations.
- Source :
-
Epilepsia [Epilepsia] 2018 Feb; Vol. 59 (2), pp. 389-402. Date of Electronic Publication: 2018 Jan 08. - Publication Year :
- 2018
-
Abstract
- Objective: Pathogenic SLC6A1 variants were recently described in patients with myoclonic atonic epilepsy (MAE) and intellectual disability (ID). We set out to define the phenotypic spectrum in a larger cohort of SCL6A1-mutated patients.<br />Methods: We collected 24 SLC6A1 probands and 6 affected family members. Four previously published cases were included for further electroclinical description. In total, we reviewed the electroclinical data of 34 subjects.<br />Results: Cognitive development was impaired in 33/34 (97%) subjects; 28/34 had mild to moderate ID, with language impairment being the most common feature. Epilepsy was diagnosed in 31/34 cases with mean onset at 3.7 years. Cognitive assessment before epilepsy onset was available in 24/31 subjects and was normal in 25% (6/24), and consistent with mild ID in 46% (11/24) or moderate ID in 17% (4/24). Two patients had speech delay only, and 1 had severe ID. After epilepsy onset, cognition deteriorated in 46% (11/24) of cases. The most common seizure types were absence, myoclonic, and atonic seizures. Sixteen cases fulfilled the diagnostic criteria for MAE. Seven further patients had different forms of generalized epilepsy and 2 had focal epilepsy. Twenty of 31 patients became seizure-free, with valproic acid being the most effective drug. There was no clear-cut correlation between seizure control and cognitive outcome. Electroencephalography (EEG) findings were available in 27/31 patients showing irregular bursts of diffuse 2.5-3.5 Hz spikes/polyspikes-and-slow waves in 25/31. Two patients developed an EEG pattern resembling electrical status epilepticus during sleep. Ataxia was observed in 7/34 cases. We describe 7 truncating and 18 missense variants, including 4 recurrent variants (Gly232Val, Ala288Val, Val342Met, and Gly362Arg).<br />Significance: Most patients carrying pathogenic SLC6A1 variants have an MAE phenotype with language delay and mild/moderate ID before epilepsy onset. However, ID alone or associated with focal epilepsy can also be observed.<br /> (Wiley Periodicals, Inc. © 2018 International League Against Epilepsy.)
- Subjects :
- Adolescent
Adult
Anticonvulsants therapeutic use
Ataxia complications
Ataxia genetics
Ataxia physiopathology
Child
Child, Preschool
Cohort Studies
Electroencephalography
Epilepsies, Myoclonic complications
Epilepsies, Myoclonic drug therapy
Epilepsies, Myoclonic genetics
Epilepsies, Partial complications
Epilepsies, Partial drug therapy
Epilepsies, Partial genetics
Epilepsies, Partial physiopathology
Epilepsy, Generalized complications
Epilepsy, Generalized drug therapy
Epilepsy, Generalized genetics
Epilepsy, Generalized physiopathology
Female
Genetic Association Studies
Humans
Intellectual Disability complications
Intellectual Disability genetics
Language Development Disorders complications
Language Development Disorders genetics
Male
Mutation
Mutation, Missense
Neurodevelopmental Disorders complications
Neurodevelopmental Disorders genetics
Phenotype
Treatment Outcome
Valproic Acid therapeutic use
Young Adult
Epilepsies, Myoclonic physiopathology
GABA Plasma Membrane Transport Proteins genetics
Intellectual Disability physiopathology
Language Development Disorders physiopathology
Subjects
Details
- Language :
- English
- ISSN :
- 1528-1167
- Volume :
- 59
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Epilepsia
- Publication Type :
- Academic Journal
- Accession number :
- 29315614
- Full Text :
- https://doi.org/10.1111/epi.13986